Digoxin antibody prevents cerebral hemorrhage-induced hypertension

João C Menezes1, Varujan Dichtchekenian

  • 1Basic Research Laboratory, Nephrology (LIM-12), Medicine School, Sao Paulo University, Sao Paulo, Brazil.

Insights

Intracerebroventricular hemorrhage increases blood pressure and serum ouabain-like compound (OLC). Digoxin antibody effectively reversed these hypertension effects in a rat model.

Area of Science:

  • Neuroscience
  • Cardiovascular Physiology

Background:

  • Brain injury can lead to hypertension.
  • Serum ouabain-like compound (OLC) possesses vasoconstrictor properties.
  • Investigating the antihypertensive potential of digoxin antibody is crucial.

Purpose of the Study:

  • To evaluate the antihypertensive effects of digoxin antibody.
  • To assess the role of serum OLC in hypertension induced by intracerebroventricular (ICV) hemorrhage.

Main Methods:

  • Wistar rats were divided into four ICV infused groups: control, blood, blood plus digoxin antibody, and cerebrospinal fluid-like solution.
  • Measurements included tail-cuff blood pressure, cumulative sodium balance, and serum OLC levels.
  • An intracerebroventricular hemorrhage rat model was utilized.

Main Results:

  • ICV blood infusion significantly increased blood pressure (BP) and serum OLC without altering sodium balance.
  • Administration of digoxin antibody successfully prevented the rise in BP and OLC.
  • A positive correlation was observed between BP and OLC in relevant rat groups (R = 0.63; P <.05).

Conclusions:

  • Cerebral hemorrhage is associated with increased OLC levels and elevated BP.
  • Digoxin antibody administration demonstrated a reversal of OLC and BP increases.
  • These findings suggest a therapeutic role for digoxin antibody in managing hypertension post-cerebral hemorrhage.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...